Current:Home > MyTornado-damaged Pfizer plant in North Carolina restarts production -AssetLink
Tornado-damaged Pfizer plant in North Carolina restarts production
View
Date:2025-04-21 15:59:48
ROCKY MOUNT, N.C. (AP) — A major Pfizer pharmaceutical plant in North Carolina that makes critical supplies for U.S. hospitals has restarted production about 10 weeks after it was heavily damaged by a tornado, the company announced Monday.
Getting a majority of manufacturing lines at the Rocky Mount facility back up and running is a “proud achievement,” Pfizer said in a statement. Full production across the facility’s three manufacturing sites is expected by the end of the year.
Parts of the massive plant’s roofs were ripped open and pallets of medicine tossed around when the tornado touched down on July 19. But most of the damage was to a storage facility for raw materials, packaging supplies and finished medicines, rather than its medicine production areas, Pfizer said. No employees were hurt.
The plant produces anesthesia and other drugs as well as nearly one-fourth of the sterile injectable medications Pfizer supplies to U.S. hospitals, the company said.
Thirteen medicines were prioritized based on patient need and inventory levels, and are now back in production on the lines that have restarted, Pfizer said. The medicines are expected to ship to distribution centers in the fourth quarter of this year. Although manufacturing has resumed, the company said some medicines may not be back in full supply until next year.
veryGood! (11)
Related
- Which apps offer encrypted messaging? How to switch and what to know after feds’ warning
- Immerse yourself in this colossal desert 'City' — but leave the selfie stick at home
- Oklahoma attorney general joins lawsuit over tribal gambling agreements, criticizes GOP governor
- Our 2023 Pop Culture Resolutions
- Gen. Mark Milley's security detail and security clearance revoked, Pentagon says
- Transgender patients sue the hospital that provided their records to Tennessee’s attorney general
- In 'Nanny,' an undervalued caretaker must contend with spirits and rage
- Work from home as a drive-thru employee? How remote blue-collar jobs are catching on
- This was the average Social Security benefit in 2004, and here's what it is now
- Investigators pore over evidence from the home of alleged Gilgo Beach serial killer as search ends
Ranking
- Alex Murdaugh’s murder appeal cites biased clerk and prejudicial evidence
- Why Twitter's rebrand to X could be legally challenging
- Family desperate for answers after 39-year-old woman vanishes
- How do I stop a co-worker who unnecessarily monitors my actions? Ask HR
- Which apps offer encrypted messaging? How to switch and what to know after feds’ warning
- Former Georgia linebacker Adam Anderson receives one-year sentence for sexual battery
- Remembering the artists, filmmakers, actors and writers we lost in 2022
- Baby raccoon's pitiful cries for mom are heartbreaking. Watch a boater step in to help.
Recommendation
McKinsey to pay $650 million after advising opioid maker on how to 'turbocharge' sales
DeSantis uninjured in car accident in Tennessee, campaign says
Rep. Maxwell Frost on Gen-Z politics and the price tag of power
Banc of California to buy troubled PacWest Bancorp, which came close to failing earlier this year
Are Instagram, Facebook and WhatsApp down? Meta says most issues resolved after outages
AMC stock pushed higher by 'Barbie', 'Oppenheimer' openings, court decision
Georgia ports had their 2nd-busiest year despite a decline in retail cargo
Interest Rates: Will the Federal Reserve pause, hike, then pause again?